Impella CP Improves Survival in STEMI, Cardiogenic Shock Impella CP Improves Survival in STEMI, Cardiogenic Shock

Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Source Type: news